- Home
- AEI vs KZIA Comparison
AEI vs KZIA Comparison
Compare AEI & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- KZIA
- Stock Information
- Founded
- AEI 2014
- KZIA 1994
- Country
- AEI United States
- KZIA Australia
- Employees
- AEI N/A
- KZIA N/A
- Industry
- AEI Building operators
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- AEI Real Estate
- KZIA Health Care
- Exchange
- AEI Nasdaq
- KZIA Nasdaq
- Market Cap
- AEI 13.4M
- KZIA 12.6M
- IPO Year
- AEI N/A
- KZIA 1999
- Fundamental
- Price
- AEI $1.46
- KZIA $0.53
- Analyst Decision
- AEI
- KZIA Strong Buy
- Analyst Count
- AEI 0
- KZIA 1
- Target Price
- AEI N/A
- KZIA $2.00
- AVG Volume (30 Days)
- AEI 74.2K
- KZIA 1.4M
- Earning Date
- AEI 11-12-2024
- KZIA 10-22-2024
- Dividend Yield
- AEI N/A
- KZIA N/A
- EPS Growth
- AEI N/A
- KZIA N/A
- EPS
- AEI N/A
- KZIA N/A
- Revenue
- AEI $9,220,976.00
- KZIA $382.00
- Revenue This Year
- AEI N/A
- KZIA $4,053,954.00
- Revenue Next Year
- AEI N/A
- KZIA N/A
- P/E Ratio
- AEI N/A
- KZIA N/A
- Revenue Growth
- AEI N/A
- KZIA N/A
- 52 Week Low
- AEI $0.46
- KZIA $0.19
- 52 Week High
- AEI $2.05
- KZIA $1.58
- Technical
- Relative Strength Index (RSI)
- AEI 53.17
- KZIA 66.52
- Support Level
- AEI $1.42
- KZIA $0.38
- Resistance Level
- AEI $1.67
- KZIA $0.46
- Average True Range (ATR)
- AEI 0.20
- KZIA 0.05
- MACD
- AEI -0.01
- KZIA 0.00
- Stochastic Oscillator
- AEI 41.10
- KZIA 85.68
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.